6-{4-[3-(2-Hydroxyethylamino)propanoyl]piperazin-1-yl}-9-methoxy-11H-indeno[1,2-c]quinolin-11-one

ID: ALA3585498

PubChem CID: 122179630

Max Phase: Preclinical

Molecular Formula: C26H28N4O4

Molecular Weight: 460.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)C(=O)c1c-2c(N2CCN(C(=O)CCNCCO)CC2)nc2ccccc12

Standard InChI:  InChI=1S/C26H28N4O4/c1-34-17-6-7-18-20(16-17)25(33)23-19-4-2-3-5-21(19)28-26(24(18)23)30-13-11-29(12-14-30)22(32)8-9-27-10-15-31/h2-7,16,27,31H,8-15H2,1H3

Standard InChI Key:  CBQBVWNXIQFQIK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    3.5632   -2.4942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5431   -1.4253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0754    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0934   -2.2270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5812   -0.7794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4942    0.2895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0934    1.7370    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6236    2.0488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1433    3.4707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3241    3.7793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7907    5.2049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7893    6.3217    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6786    6.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1451    4.5874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0891   -0.4677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3340    0.9353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690   -1.3585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2938   -0.4677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8484    0.9353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8728    2.0488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3426    1.7370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8103    0.2672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7636   -0.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2691   -0.0829    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6106   -1.2332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0528   -2.5584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2532    7.7491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4271    7.9981    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2497    8.8651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7136   10.2924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2899   11.4085    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1740   12.8358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8295   13.9518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4586   15.0931    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8 16  1  0
 15  5  1  0
  9 10  1  0
  9 14  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  8  9  1  0
 15 16  2  0
 16 19  1  0
 18 17  1  0
 17 15  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 22 24  1  0
 24 25  1  0
 17 26  2  0
 12 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3585498

    ---

Associated Targets(Human)

Detroit 551 (346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1299 (3248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGS (1999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SAS (201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 460.53Molecular Weight (Monoisotopic): 460.2111AlogP: 2.08#Rotatable Bonds: 7
Polar Surface Area: 95.00Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.13CX LogP: 1.94CX LogD: 0.21
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.41Np Likeness Score: -0.52

References

1. Tseng C, Tzeng C, Chiu C, Yang C, Lu P, Chou C, Liu C, Chen Y.  (2014)  Synthesis and antiproliferative evaluation of 9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinoline-11-one derivatives. Part 4,  (7): [10.1039/C4MD00133H]

Source